Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Understanding POEM syndrome: Diagnosis and treatment challenges

Philippine College of Hematology and Transfusion Medicine: 3rd Midyear Convention

21 - 23 Mar 2025

Published: 22 Apr 2025

Views: 400

Rating:

Save

Dr Deonne Thaddeus Gauiran - University of the Philippines, Manila, Philippines

POEM syndrome is a rare disease affecting the nervous system, with symptoms like polyneuropathy. It impacts about 0.3 in a hundred thousand people, and misdiagnosis can lead to chronic issues.

Diagnostic criteria are often inaccessible, especially in the Philippines. Treatment mainly involves autologous stem cell transplantation, but other medications can worsen neuropathy.

A multidisciplinary approach is essential for effective management and raising awareness is crucial.

Related Videos

Advances in multiple myeloma treatment in the Philippines

Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila, Philippines

Advances in multiple myeloma treatment in the Philippines ( Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila, Philippines )

Exploring the National Access Subcutaneous Trastuzumab Program in Kenya

Dr Jean Kasudi - University of Kenya, Nairobi, Kenya

Exploring the National Access Subcutaneous Trastuzumab Program in Kenya ( Dr Jean Kasudi - University of Kenya, Nairobi, Kenya )

The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America

Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala

The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America ( Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala )

Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC

Dr Thomas Zilli - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC ( Dr Thomas Zilli - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions

Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions ( Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia )

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Advancements in paediatric Acute lymphoblastic leukemia management

Dr Ruchi Aujla - Balco Medical Center, Raipur, India

Advancements in paediatric Acute lymphoblastic leukemia management ( Dr Ruchi Aujla - Balco Medical Center, Raipur, India )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients

Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients ( Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea )

More from ecancer